NUOVO CAPITOLO NELLA VICENDA GRAIL/ILLUMINA. LA COMMISSIONE INVIA UNA NUOVA COMUNICAZIONE DEGLI ADDEBITI

marketude Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

ABUSO DI POSIZIONE DOMINANTE NEL MERCATO DEI FARMACI A BASE DI FERRO. LA SVIZZERA VIFOR PHARMA SOTTO INDAGINE DA PARTE DELLA COMMISSIONE

marketude Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences, Pharmaceuticals and Life Sciences

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

PROPRIETÀ INTELLETTUALE E PIATTAFORME ONLINE. L’AG SZPUNAR SI PRONUNCIA NEL SENSO DELL’IMPOSSIBILITÀ, PER IL TITOLARE DEL MARCHIO, DI VIETARE L’USO DA PARTE DEL GESTORE DI UN MERCATO ONLINE DI UN SEGNO IDENTICO O SIMILE PER PRODOTTI O SERVIZI IDENTICI O SIMILI

marketude Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo, Marco Stillo

[x_icon type="tag"] EU and Competition, Intellectual Property, Litigation

LA CRISI UCRAINA E IL SESTO PACCHETTO DI SANZIONI

marketude Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law, Constitutional and International Law

[x_icon type="tag"] EU and Competition, Constitutional and International Law, Ukraine and International Sanctions, Perspectives

CRISI UCRAINA E RIFUGIATI. LA PROPOSTA DELLA COMMISSIONE PER UN’AZIONE DI COESIONE

marketude Mobility, Mobility, Mobility, Mobility, Mobility, Mobility, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives, Perspectives

[x_icon type="tag"] EU and Competition, Mobility, Perspectives, Ukraine and International sanctions

UKRAINE CRISIS. THE EU COUNCIL ADOPTS A PACKAGE OF MEASURES TOWARDS RUSSIA

marketude Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions, Ukraine and international sanctions

[x_icon type="tag"] EU and Competition, Constitutional and International Law, Perspectives

TRATTAMENTO DEI DATI PERSONALI. L’AG DE LA TOUR SI PRONUNCIA SULLA LEGITTIMAZIONE AD AGIRE DI UN’ASSOCIAZIONE PER LA TUTELA DEGLI INTERESSI DEI CONSUMATORI

marketude Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, Data Protection and Cybersecurity, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition, EU and Competition

[x_icon type="tag"] EU and Competition, Data Protection and Cybersecurity, Litigation

USO IMPROPRIO DI BREVETTI E ANTITRUST NEGLI USA (CASO PHARMAVITE C. BAUSCH & LOMB INCORPORATED E CONSUMER HEALTHCARE)

marketude Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation, Litigation

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Litigation, Perspectives

SPERIMENTAZIONI CLINICHE. ORAMAI ALLE PORTE L’ENTRATA IN VIGORE DEL NUOVO REGOLAMENTO 536/2014

marketude Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives